Eli Casdin

Insider Reports History

Entity
Individual
Location
1350 Avenue Of The Americas, Suite 1140, New York, NY
Signature
/s/ Eli Casdin by Agnieszka Gallagher, Attorney-in-Fact
All insider transactions
Transactions in reports broken out by “transaction date” reported in original SEC filing, see here for transactions aggregated across transaction date

Holdings reported by Eli Casdin:

Stock Role Class Num Shares Value Price $ Report Date Ownership
STANDARD BIOTOOLS INC. Director, 10%+ Owner Common Stock 46.7M $95.8M $2.05 Jul 19, 2024 Casdin Partners Master Fund, L.P
GeneDx Holdings Corp. Director, 10%+ Owner Class A Common Stock 3.09M $87.6M $28.31 Jun 20, 2024 See Casdin Partners Master Fund, LP
STANDARD BIOTOOLS INC. Director, 10%+ Owner Common Stock 13.9M $28.6M $2.05 Jul 19, 2024 Casdin Private Growth Equity Fund II, L.P.
Tenaya Therapeutics, Inc. Director Common Stock 6.08M $25.9M $4.26 Nov 17, 2022 Indirect
GeneDx Holdings Corp. Director, 10%+ Owner Class A Common Stock 433K $12.3M $28.31 Jun 20, 2024 See Casdin Partners F01-MSV, LP
GeneDx Holdings Corp. Director, 10%+ Owner Class A Common Stock 333K $9.43M $28.31 Jun 20, 2024 See CMLS Holdings LLC
STANDARD BIOTOOLS INC. Director, 10%+ Owner Common Stock 2.75M $5.64M $2.05 Jul 19, 2024 Direct
STANDARD BIOTOOLS INC. Director, 10%+ Owner Common Stock 2.74M $5.63M $2.05 Jul 19, 2024 By Casdin Private Growth Equity Fund, L.P.
STANDARD BIOTOOLS INC. Director, 10%+ Owner Common Stock 545K $1.12M $2.05 Jul 19, 2024 Casdin Amplify Fund, LP
GeneDx Holdings Corp. Director, 10%+ Owner Restricted Stock Unit 12.9K $366K $28.31 Jun 26, 2024 Direct
STANDARD BIOTOOLS INC. Director, 10%+ Owner Stock Option (Right to buy) 72.2K $270K $3.74 Jun 28, 2024 Direct
GeneDx Holdings Corp. Director, 10%+ Owner Class A Common Stock 7.59K $215K $28.31 Jun 20, 2024 Direct
STANDARD BIOTOOLS INC. Director, 10%+ Owner Common Stock 18.9K $38.7K $2.05 Jul 19, 2024 Indirect
STANDARD BIOTOOLS INC. Director, 10%+ Owner Warrant to purchase common stock (Right to buy) 4.82M Jan 5, 2024 CMLS Holdings LLC
Tenaya Therapeutics, Inc. Director Warrant 1.35M Nov 17, 2022 Indirect
Tenaya Therapeutics, Inc. Director Stock Option (Right to buy) 39.7K Jun 10, 2022 Direct
Absci Corp Director Stock Option (right to buy) 28.7K Jun 8, 2022 Direct
Century Therapeutics, Inc. Director Stock Option (right to buy) 19.9K Jun 9, 2022 Direct
GeneDx Holdings Corp. Director, 10%+ Owner Stock Option (Right to Buy) 8.82K Jul 21, 2023 Direct
EQRx, Inc. 10%+ Owner Common Stock 0 $2.21 Nov 9, 2023 Indirect
EQRx, Inc. 10%+ Owner Earn-out Shares 0 Nov 9, 2023 Indirect
EQRx, Inc. 10%+ Owner Stock Option (Right to Buy) 0 Nov 9, 2023 Direct
EQRx, Inc. 10%+ Owner Warrants to purchase Class A Common Stock (right to buy) 0 Nov 9, 2023 Indirect
SomaLogic, Inc. Director, 10%+ Owner Common Stock 0 $2.43 Jan 5, 2024 By Casdin Master Fund, L.P.
SomaLogic, Inc. Director, 10%+ Owner Common Stock 0 $2.43 Jan 5, 2024 By Casdin Private Growth Equity Fund, L.P.
SomaLogic, Inc. Director, 10%+ Owner Common Stock 0 $2.43 Jan 5, 2024 By CMLS Holdings II LLC
SomaLogic, Inc. Director, 10%+ Owner Common Stock 0 $2.43 Jan 5, 2024 Direct
SomaLogic, Inc. Director, 10%+ Owner Restricted Stock Unit 0 $2.43 Jan 5, 2024 Direct
SomaLogic, Inc. Director, 10%+ Owner Stock Option (Right to buy) 0 Jan 5, 2024 Direct
SomaLogic, Inc. Director, 10%+ Owner Warrant to purchase common stock (Right to buy) 0 Jan 5, 2024 By CMLS Holdings II LLC

Insider Reports Filed by Eli Casdin

Symbol Company Period Transactions Value $ Form Type Date Filed Role
LAB STANDARD BIOTOOLS INC. Jul 19, 2024 1 $0 4 Jul 23, 2024 Director, 10%+ Owner
LAB STANDARD BIOTOOLS INC. Jun 28, 2024 2 $0 4 Jul 2, 2024 Director, 10%+ Owner
WGS GeneDx Holdings Corp. Jun 26, 2024 1 $0 4 Jun 27, 2024 Director, 10%+ Owner
WGS GeneDx Holdings Corp. Jun 20, 2024 2 $0 4 Jun 24, 2024 Director, 10%+ Owner
LAB STANDARD BIOTOOLS INC. Feb 20, 2024 1 $57K 4 Feb 22, 2024 Director, 10%+ Owner
SLGC SomaLogic, Inc. Jan 5, 2024 10 $0 4 Jan 9, 2024 Director, 10%+ Owner
LAB STANDARD BIOTOOLS INC. Jan 5, 2024 10 $0 4 Jan 9, 2024 Director, 10%+ Owner
EQRX EQRx, Inc. Nov 9, 2023 9 $0 4 Nov 14, 2023 10%+ Owner
WGS GeneDx Holdings Corp. Jul 21, 2023 2 $0 4 Jul 25, 2023 Director, 10%+ Owner
LAB STANDARD BIOTOOLS INC. Jun 14, 2023 2 $0 4 Jun 16, 2023 Director
LAB STANDARD BIOTOOLS INC. May 17, 2023 3 $2.63M 4 May 19, 2023 Director, 10%+ Owner
WGS GeneDx Holdings Corp. May 2, 2023 2 $0 4 May 4, 2023 Director
SLGC SomaLogic, Inc. Mar 17, 2023 2 $0 4 Mar 22, 2023 Director
WGS GeneDx Holdings Corp. Jan 31, 2023 2 $30M 4 Feb 2, 2023 Director, 10%+ Owner
EQRX EQRx, Inc. Jan 1, 2023 3 $0 4 Jan 4, 2023 10%+ Owner
TNYA Tenaya Therapeutics, Inc. Nov 17, 2022 2 $10M 4 Nov 25, 2022 Director
EQRX EQRx, Inc. Sep 30, 2022 1 $0 4 Oct 4, 2022 Director, 10%+ Owner
SLGC SomaLogic, Inc. Sep 29, 2022 1 $0 4 Dec 14, 2022 Director
LAB STANDARD BIOTOOLS INC. Jun 15, 2022 2 $79.2K 4 Jun 17, 2022 Director
TNYA Tenaya Therapeutics, Inc. Jun 10, 2022 1 $0 4 Jun 13, 2022 Director
IPSC Century Therapeutics, Inc. Jun 9, 2022 1 $0 4 Jun 10, 2022 Director
ABSI Absci Corp Jun 8, 2022 1 $0 4 Jun 10, 2022 Director
WGSWW Sema4 Holdings Corp. May 2, 2022 1 $0 4/A May 6, 2022 Director
WGSWW Sema4 Holdings Corp. Apr 29, 2022 1 $45.8M 4 May 3, 2022 Director
WGSWW Sema4 Holdings Corp. Apr 27, 2022 2 $0 4 May 12, 2022 Director
LAB STANDARD BIOTOOLS INC. Apr 4, 2022 3 $0 4 Apr 6, 2022 Director, 10%+ Owner
LAB STANDARD BIOTOOLS INC. Apr 4, 2022 0 $0 3 Apr 6, 2022 Director
SLGC SomaLogic, Inc. Mar 1, 2022 2 $0 4 Mar 3, 2022 Director
EQRX EQRx, Inc. Dec 17, 2021 13 $50M 4/A Dec 23, 2021 Director, 10%+ Owner
SLGC SomaLogic, Inc. Oct 27, 2021 1 $0 4 Dec 13, 2021 Director
WGSWW Sema4 Holdings Corp. Oct 15, 2021 2 $0 4 Oct 19, 2021 Director
SLGC SomaLogic, Inc. Sep 1, 2021 5 $25M 4 Sep 3, 2021 Director
TNYA Tenaya Therapeutics, Inc. Aug 3, 2021 6 $12.8M 4 Aug 4, 2021 Director, 10%+ Owner
TNYA Tenaya Therapeutics, Inc. Jul 29, 2021 0 $0 3 Jul 29, 2021 Director, 10%+ Owner
ABSI Absci Corp Jul 26, 2021 7 -$538K 4 Jul 28, 2021 Director
WGSWW Sema4 Holdings Corp. Jul 22, 2021 4 $0 4 Jul 27, 2021 Director
ABSI Absci Corp Jul 21, 2021 0 $0 3 Jul 21, 2021 Director, 10%+ Owner
IPSC Century Therapeutics, Inc. Jun 22, 2021 3 $15M 4 Jun 22, 2021 Director
IPSC Century Therapeutics, Inc. Jun 17, 2021 1 $0 4 Jun 21, 2021 Director
IPSC Century Therapeutics, Inc. Jun 17, 2021 0 $0 3 Jun 17, 2021 Director